Canaccord Slashes AeroVironment Target From $400 to $330 but Holds Buy - Here's What That Contradiction Means

"The Pentagon's decision to open the SCAR phased array flat panel antenna program to competition from additional vendors is the core issue. SCAR is a BlueHalo product line sitting inside the Space, Cyber and Directed Energy (SCDE) segment, which generated $170.94 million in Q2 FY26 revenue. AeroVironment paid $4.1 billion to acquire BlueHalo, and SCAR was one of the flagship programs justifying that price tag."

"Moving from sole-source to competitive procurement is, as Canaccord noted, consistent with the Pentagon's current acquisition strategy across most programs. That doesn't make it painless. Revenue visibility in the SCDE segment just got cloudier, and the market is repricing accordingly."

"AVAV is trading at $226, down 11% over the past week and 12% over the past month. The stock sits 34.67% below its 52-week high. Against the consensus target of $359.29, that's a substantial implied upside - but only if the bull case holds."

"Q2 FY26 produced a record $3.50 billion in contract awards ceiling value, a book-to-bill ratio of 2.9x, and a $874 million FMS IDIQ for UAS and Switchblade systems. A $186 million U.S. Army Switchblade order was announced Feb"

AeroVironment's stock has declined 11% weekly and 12% monthly, trading at $226 against a consensus analyst target of $359.29. The primary concern stems from the Pentagon's decision to open the SCAR phased array flat panel antenna program to competitive procurement, shifting from sole-source contracting. SCAR is a BlueHalo product within the Space, Cyber and Directed Energy segment, which generated $170.94 million in Q2 FY26 revenue. This program was central to justifying AeroVironment's $4.1 billion BlueHalo acquisition. Canaccord cut its price target from $400 to $330 while maintaining a Buy rating, signaling confidence in long-term prospects but acknowledging near-term program risk. Raymond James downgraded the stock from Strong Buy to Underperform, citing concerns about the company's largest program. Despite these headwinds, the bull case rests on record backlog metrics including a 2.9x book-to-bill ratio and $3.50 billion in Q2 FY26 contract awards.

Read at 24/7 Wall St.